Comparison of induction methods for supersaturation: Amorphous dissolution versus solvent shift

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Comparison of induction methods for supersaturation : Amorphous dissolution versus solvent shift. / Plum, Jakob; Bavnhoj, Christoffer G.; Eliasen, Jannik N.; Rades, Thomas; Muellertz, Anette.

In: European Journal of Pharmaceutics and Biopharmaceutics, Vol. 152, 2020, p. 35-43.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Plum, J, Bavnhoj, CG, Eliasen, JN, Rades, T & Muellertz, A 2020, 'Comparison of induction methods for supersaturation: Amorphous dissolution versus solvent shift', European Journal of Pharmaceutics and Biopharmaceutics, vol. 152, pp. 35-43. https://doi.org/10.1016/j.ejpb.2020.04.017

APA

Plum, J., Bavnhoj, C. G., Eliasen, J. N., Rades, T., & Muellertz, A. (2020). Comparison of induction methods for supersaturation: Amorphous dissolution versus solvent shift. European Journal of Pharmaceutics and Biopharmaceutics, 152, 35-43. https://doi.org/10.1016/j.ejpb.2020.04.017

Vancouver

Plum J, Bavnhoj CG, Eliasen JN, Rades T, Muellertz A. Comparison of induction methods for supersaturation: Amorphous dissolution versus solvent shift. European Journal of Pharmaceutics and Biopharmaceutics. 2020;152:35-43. https://doi.org/10.1016/j.ejpb.2020.04.017

Author

Plum, Jakob ; Bavnhoj, Christoffer G. ; Eliasen, Jannik N. ; Rades, Thomas ; Muellertz, Anette. / Comparison of induction methods for supersaturation : Amorphous dissolution versus solvent shift. In: European Journal of Pharmaceutics and Biopharmaceutics. 2020 ; Vol. 152. pp. 35-43.

Bibtex

@article{a97acbc400f943dca628440f50a2e846,
title = "Comparison of induction methods for supersaturation: Amorphous dissolution versus solvent shift",
abstract = "Simple solvent shift is often used to induce supersaturation and investigate precipitation kinetics in early drug development as a substitute for amorphous dissolution. This study develops and compares a small-scale non-sink amorphous dissolution method to a solvent shift method as induction methods for supersaturation of the model drugs albendazole, felodipine and tadalafil with respect to the maximum dissolved drug concentration, and the solid form of the precipitate. The study also investigates the effect of pre-dispersed precipitation inhibitors (hydroxypropyl methyl cellulose (HPMC) or polyvinylpyrrolidone (PVP)) on tadalafil supersaturation induced by both amorphous dissolution and solvent shift with respect to maximum dissolved drug concentration, precipitation rate and solid form of the precipitate. The maximum drug concentrations achieved through solvent shift were 15.9, 208 and 108 mu g/mL for albendazole, felodipine and tadalafil, respectively. Pre-dispersing 0.1% (w/v) HPMC or PVP, increased the maximum concentration by solvent shift of tadalafil to 180 mu g/mL, for both polymers. Dissolution of up to 90 mg albendazole, 120 mg felodipine and 8.9 mg tadalafil could yield a maximum dissolved drug concentration of 76.1%, 87.9% and 102.5%, respectively, of the corresponding solvent shift maximum concentration. The maximum concentration achieved through amorphous dissolution of tadalafil with HPMC or PVP present in the dissolution medium was 87.1% and 88.7%, respectively of the solvent shift maximum concentration. Dissolution of 2 mg amorphous tadalafil with and without pre-dispersed polymer gave the same rank order of onset of precipitation as for the solvent shift method. The solid form of precipitate was the same for albendazole, felodipine, tadalafil and tadalafil with PVP for both methods. For tadalafil with HPMC, the precipitate was amorphous following solvent shift, but crystalline after amorphous dissolution. Overall, this study shows that the maximum concentration achievable through amorphous dissolution can be estimated when performing solvent shift and the precipitation inhibition of excipients assessed via solvent shift can be used to predict the effect on precipitation using amorphous dissolution.",
keywords = "Amorphous, Supersaturation, Precipitation inhibitors, Dissolution, GLASS-FORMING ABILITY, POORLY SOLUBLE DRUGS, APPARENT SOLUBILITY, PRECIPITATION, IMPACT, NUCLEATION, STRATEGIES, TADALAFIL, MOLECULES",
author = "Jakob Plum and Bavnhoj, {Christoffer G.} and Eliasen, {Jannik N.} and Thomas Rades and Anette Muellertz",
year = "2020",
doi = "10.1016/j.ejpb.2020.04.017",
language = "English",
volume = "152",
pages = "35--43",
journal = "European Journal of Pharmaceutics and Biopharmaceutics",
issn = "0939-6411",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Comparison of induction methods for supersaturation

T2 - Amorphous dissolution versus solvent shift

AU - Plum, Jakob

AU - Bavnhoj, Christoffer G.

AU - Eliasen, Jannik N.

AU - Rades, Thomas

AU - Muellertz, Anette

PY - 2020

Y1 - 2020

N2 - Simple solvent shift is often used to induce supersaturation and investigate precipitation kinetics in early drug development as a substitute for amorphous dissolution. This study develops and compares a small-scale non-sink amorphous dissolution method to a solvent shift method as induction methods for supersaturation of the model drugs albendazole, felodipine and tadalafil with respect to the maximum dissolved drug concentration, and the solid form of the precipitate. The study also investigates the effect of pre-dispersed precipitation inhibitors (hydroxypropyl methyl cellulose (HPMC) or polyvinylpyrrolidone (PVP)) on tadalafil supersaturation induced by both amorphous dissolution and solvent shift with respect to maximum dissolved drug concentration, precipitation rate and solid form of the precipitate. The maximum drug concentrations achieved through solvent shift were 15.9, 208 and 108 mu g/mL for albendazole, felodipine and tadalafil, respectively. Pre-dispersing 0.1% (w/v) HPMC or PVP, increased the maximum concentration by solvent shift of tadalafil to 180 mu g/mL, for both polymers. Dissolution of up to 90 mg albendazole, 120 mg felodipine and 8.9 mg tadalafil could yield a maximum dissolved drug concentration of 76.1%, 87.9% and 102.5%, respectively, of the corresponding solvent shift maximum concentration. The maximum concentration achieved through amorphous dissolution of tadalafil with HPMC or PVP present in the dissolution medium was 87.1% and 88.7%, respectively of the solvent shift maximum concentration. Dissolution of 2 mg amorphous tadalafil with and without pre-dispersed polymer gave the same rank order of onset of precipitation as for the solvent shift method. The solid form of precipitate was the same for albendazole, felodipine, tadalafil and tadalafil with PVP for both methods. For tadalafil with HPMC, the precipitate was amorphous following solvent shift, but crystalline after amorphous dissolution. Overall, this study shows that the maximum concentration achievable through amorphous dissolution can be estimated when performing solvent shift and the precipitation inhibition of excipients assessed via solvent shift can be used to predict the effect on precipitation using amorphous dissolution.

AB - Simple solvent shift is often used to induce supersaturation and investigate precipitation kinetics in early drug development as a substitute for amorphous dissolution. This study develops and compares a small-scale non-sink amorphous dissolution method to a solvent shift method as induction methods for supersaturation of the model drugs albendazole, felodipine and tadalafil with respect to the maximum dissolved drug concentration, and the solid form of the precipitate. The study also investigates the effect of pre-dispersed precipitation inhibitors (hydroxypropyl methyl cellulose (HPMC) or polyvinylpyrrolidone (PVP)) on tadalafil supersaturation induced by both amorphous dissolution and solvent shift with respect to maximum dissolved drug concentration, precipitation rate and solid form of the precipitate. The maximum drug concentrations achieved through solvent shift were 15.9, 208 and 108 mu g/mL for albendazole, felodipine and tadalafil, respectively. Pre-dispersing 0.1% (w/v) HPMC or PVP, increased the maximum concentration by solvent shift of tadalafil to 180 mu g/mL, for both polymers. Dissolution of up to 90 mg albendazole, 120 mg felodipine and 8.9 mg tadalafil could yield a maximum dissolved drug concentration of 76.1%, 87.9% and 102.5%, respectively, of the corresponding solvent shift maximum concentration. The maximum concentration achieved through amorphous dissolution of tadalafil with HPMC or PVP present in the dissolution medium was 87.1% and 88.7%, respectively of the solvent shift maximum concentration. Dissolution of 2 mg amorphous tadalafil with and without pre-dispersed polymer gave the same rank order of onset of precipitation as for the solvent shift method. The solid form of precipitate was the same for albendazole, felodipine, tadalafil and tadalafil with PVP for both methods. For tadalafil with HPMC, the precipitate was amorphous following solvent shift, but crystalline after amorphous dissolution. Overall, this study shows that the maximum concentration achievable through amorphous dissolution can be estimated when performing solvent shift and the precipitation inhibition of excipients assessed via solvent shift can be used to predict the effect on precipitation using amorphous dissolution.

KW - Amorphous

KW - Supersaturation

KW - Precipitation inhibitors

KW - Dissolution

KW - GLASS-FORMING ABILITY

KW - POORLY SOLUBLE DRUGS

KW - APPARENT SOLUBILITY

KW - PRECIPITATION

KW - IMPACT

KW - NUCLEATION

KW - STRATEGIES

KW - TADALAFIL

KW - MOLECULES

U2 - 10.1016/j.ejpb.2020.04.017

DO - 10.1016/j.ejpb.2020.04.017

M3 - Journal article

C2 - 32376371

VL - 152

SP - 35

EP - 43

JO - European Journal of Pharmaceutics and Biopharmaceutics

JF - European Journal of Pharmaceutics and Biopharmaceutics

SN - 0939-6411

ER -

ID: 259625936